T. Keistinen et al., BRONCHIECTASIS - AN ORPHAN DISEASE WITH A POORLY-UNDERSTOOD PROGNOSIS, The European respiratory journal, 10(12), 1997, pp. 2784-2787
The prognosis and risk factors for bronchiectasis are at present poorl
y known. The aim of this study was to examine the long-term prognosis
and cause of death in this disease. The National Hospital Discharge Re
gister was used to search for patients aged 35-74 yrs, with newly-diag
nosed bronchiectasis in the period 1982-1986. Each of the 842 patients
identified was matched with an asthmatic patient and a patient with c
hronic obstructive pulmonary disease (COPD), who were of the same age
and sex and who had been treated in hospital at the same time, The use
of hospital services by these subjects was examined up to the end of
1992, and mortality to the end of 1993. The prognosis for the bronchie
ctatic patients treated in hospital was better than that for the COPD
patients but poorer than that for the asthmatics; the risk of death be
ing 1.25 (95% confidence interval (95% CI) 1.15-1.36) for the CORD pat
ients and 0.79 (95% CI 0.71-0.87) for the asthmatics, relative to the
bronchiectatic patients, Bronchiectasis was the main cause of death in
13% of bronchiectatic patients, the risk of death being increased by
a factor of 1.21 in the presence of asthma as the main secondary diagn
osis, by 1.31 with COPD, by 1.35 with tuberculosis and its sequelae, a
nd by 1.32 with some other secondary diagnosis, as compared with cases
for which no secondary diagnosis was indicated; The fact that the pro
gnosis for bronchiectatic patients is poorer than that for asthmatics
points to a continued need for focused care and follow-up, particularl
y in the presence of additional illnesses.